5-(1-ethyl-1H-indazol-5-yl)-2-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4H,7H-pyrazolo[1,5-a]pyrimidin-7-one

ID: ALA3717514

PubChem CID: 136509775

Max Phase: Preclinical

Molecular Formula: C19H17N7O2

Molecular Weight: 375.39

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCn1ncc2cc(-c3cc(=O)n4nc(C)c(-c5nc(C)no5)c4[nH]3)ccc21

Standard InChI:  InChI=1S/C19H17N7O2/c1-4-25-15-6-5-12(7-13(15)9-20-25)14-8-16(27)26-18(22-14)17(10(2)23-26)19-21-11(3)24-28-19/h5-9,22H,4H2,1-3H3

Standard InChI Key:  FXWMEDKPGQUELM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028    1.5132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028   -1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138   -1.2033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9991   -2.7132    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6243    2.9682    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7308    4.4645    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3406    5.0280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3751    3.8801    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1749    2.6315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0517    6.1927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7889    0.0269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6395    3.4592    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5184    2.2403    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6468    1.0526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2234    1.5040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9312    0.7344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6168    1.4950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6117    2.9912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9221    3.7609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2188    2.9991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1069    4.8826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2813    5.1293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  7  8  2  0
  8  9  1  0
  6  7  1  0
  1  9  2  0
  5 10  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 11 15  1  0
 13 16  1  0
  9 15  1  0
  8 17  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 18 26  1  0
 21 26  2  0
 27 28  1  0
 18 27  1  0
  3 23  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3717514

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 375.39

Molecular Weight (Monoisotopic): 375.1444

AlogP: 2.73

#Rotatable Bonds: 3

Polar Surface Area: 106.90

Molecular Species: NEUTRAL

HBA: 8

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 10.60

CX Basic pKa: 1.15

CX LogP: 1.75

CX LogD: 1.75

Aromatic Rings: 5

Heavy Atoms: 28

QED Weighted: 0.52

Np Likeness Score: -2.04

References

1.  (2014)  Heterocyclic compounds for the inhibition of pask, 

2.  (2015)  Heterocyclic compounds for the inhibition of pask, 

Source

Source(1):

• Patent Bioactivity Data